Resources

This landscape of respiratory care equipment distributors across sub-Saharan Africa is intended to provide market insights into distributors in the region who can provide quality products and after-sales support. The distributors represented in this landscape were prioritized based on their geographic reach, quality assurance, and/or strong after-sales services. Each company completed a survey about their respective capabilities and engaged in follow-up discussions to further clarify their offerings. In this version (November 2021), products with stringent regulatory authority (SRA) approval were prioritized for inclusion. We will continue to build on this landscape as further engagement takes place.If your company supplies respiratory care equipment, has presence in sub-Saharan Africa, and would like to be considered for inclusion, please complete this short survey.

Middle-income countries not eligible for support from Gavi, the Vaccine Alliance, have been slow to introduce rotavirus vaccines, largely due to cost concerns. A PATH analysis shows that, in most cases, rotavirus vaccination is likely to be highly cost-effective and beneficial for these countries.Brief is available in English, French, Russian, and Spanish.

Medical oxygen has for too long been an afterthought among the competing priorities of global health. It is a World Health Organization essential medicine and necessary treatment for acute and chronic conditions alike, but inequitable access, production shortages, logistical failures, and a host of additional circumstances have inhibited the widespread adoption and consistent provision of this lifesaving resource.The COVID-19 pandemic has given added salience to the importance of medical oxygen and made stark the seriousness that a lack of access creates. As governments and health systems come to terms with the harsh realities that the pandemic has laid bare, and the resulting political capital and social engagement is mustered, there is a robust opportunity to make inroads against this inequity and help ensure that patients the world over can again breathe easy—in more ways than one.This supply intelligence brief series, Oxygen Generation and Storage, is intended to be a concise primer for decision-makers who govern, lead, support, or manage health systems and their associated facilities. Providing an overview of the key elements that define each technology—as well as key considerations related to COVID-19—it can establish a starting point for understanding the solutions available to meet a health system’s need for medical oxygen and its delivery. It should serve alongside a broader suite of planning and analytical requirements necessary for the implementation of medical oxygen solutions.

People at risk for or living with HIV have an elevated risk of mental health morbidities. Poor mental health among these key populations can reduce quality of life and impact care seeking, adherence to and continuation of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP)—two critical interventions for treating and preventing HIV. Seeing this gap in successful HIV care, the USAID/PATH Healthy Markets project sought to make mental health care more accessible for people at risk for or living with HIV.

Oxygen therapy is essential to treat a broad range of diseases that affect multiple patient populations. However, government officials involved in the Global Financing Facility (GFF) process are often unaware of wide gaps in oxygen access or of its capacity to improve health outcomes, particularly for vulnerable populations such as pregnant women, newborns, and children. As a result, many countries may be engaged with the GFF, but the GFF investment case is underrecognized and underused as a tool to support medical oxygen access.This Global Financing Facility Oxygen Investment Case Guide describes how the GFF investment case process can be leveraged to increase access to medical oxygen and is intended for use by civil society and government decision-makers. Presented in this guide are practical approaches and actions that civil society and government can use throughout the GFF process to include medical oxygen both proactively during GFF investment case development, as well as later, during implementation of an investment case.This tool is part of the Oxygen Delivery Toolkit: Resources to plan and scale medical oxygen. The materials provided within the toolkit can be used together or separately, as needed. The complete toolkit is available at www.path.org/oxygen-delivery-toolkit.